By The Press Association2013-08-27T12:51:00
Cancer patients in Wales are more than four times less likely to receive a newer drug on the NHS than those in England, it is claimed.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud